Agree. On science taking its time, one thing that baffles me is that in the US and the UK, HCQ trials are only starting, as we reach the tail of this pandemic. Would someone know what is the rationale for waiting so long?
It’s really frustrating that the theorized mechanism of HCQ effectiveness as a prophylactic is its ability to transport zinc across cell walls (zinc interrupts the viral RNA replication), yet these trials don’t include zinc supplements.
Check the supplementary data. There were confounding factors, but a group of patients took zinc, and there is no difference between the two groups.
Bear in mind that this study has no say on the use as a treatment.